The store will not work correctly when cookies are disabled.
N-Hexyl-3-(3,4,5-trihydroxyphenyl)-2-propenamide
ID: ALA3814307
PubChem CID: 127049629
Max Phase: Preclinical
Molecular Formula: C15H21NO4
Molecular Weight: 279.34
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCCCCCNC(=O)/C=C/c1cc(O)c(O)c(O)c1
Standard InChI: InChI=1S/C15H21NO4/c1-2-3-4-5-8-16-14(19)7-6-11-9-12(17)15(20)13(18)10-11/h6-7,9-10,17-18,20H,2-5,8H2,1H3,(H,16,19)/b7-6+
Standard InChI Key: AQJFUQFYAOOZNB-VOTSOKGWSA-N
Molfile:
RDKit 2D
20 20 0 0 0 0 0 0 0 0999 V2000
-1.3070 5.2502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3039 3.7494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0031 3.0008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2688 5.8520 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3383 -1.3500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.6078 5.9988 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -2.7000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.6109 7.4996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9118 8.2481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9149 9.7490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2157 10.4975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2188 11.9983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2589 12.5968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3383 -1.3500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 6 1 0
4 2 2 0
5 9 1 0
6 8 2 0
7 1 2 0
8 4 1 0
9 12 2 0
10 3 1 0
11 1 1 0
12 8 1 0
13 5 1 0
3 5 2 0
11 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
9 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 279.34 | Molecular Weight (Monoisotopic): 279.1471 | AlogP: 2.51 | #Rotatable Bonds: 7 |
Polar Surface Area: 89.79 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 4 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.85 | CX Basic pKa: ┄ | CX LogP: 2.86 | CX LogD: 2.84 |
Aromatic Rings: 1 | Heavy Atoms: 20 | QED Weighted: 0.35 | Np Likeness Score: 0.52 |
References
1. Tavares-da-Silva EJ, Varela CL, Pires AS, Encarnação JC, Abrantes AM, Botelho MF, Carvalho RA, Proença C, Freitas M, Fernandes E, Roleira FM.. (2016) Combined dual effect of modulation of human neutrophils' oxidative burst and inhibition of colon cancer cells proliferation by hydroxycinnamic acid derivatives., 24 (16): [PMID:27290693] [10.1016/j.bmc.2016.05.065] |